Royce & Associates’s Biostage BSTG Stock Holding History
Bought
Maintained
Sold
Other funds holding BSTG
6CM
Royce & Associates's BSTG Position: Q1 2015 in Review
Royce & Associates sold out of Biostage (BSTG) in Q1 2015, closing a stake of 73,405 shares — an estimated $233K sold.
Royce & Associates first reported a position in BSTG in Q4 2013 and held it in 5 quarters. The position peaked at $1.8M in Q2 2014. 37 funds tracked by Wall St. Rank hold BSTG as of Q1 2015.
- Royce & Associates reported no remaining Biostage position as of Q1 2015 after selling out during the quarter.
- Royce & Associates sold 73,405 Biostage shares in Q1 2015, an estimated $233K.
- Royce & Associates first reported a position in Biostage in Q4 2013 and held it in 5 quarters.
- Royce & Associates's Biostage position peaked at $1.8M in Q2 2014.
- 37 funds tracked by Wall St. Rank held Biostage as of Q1 2015.
Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.